Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial

Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial

Background There have been no effective treatments for slowing or reversing Alzheimer’s disease (AD) until now. Growing preclinical evidence, including this study, suggests that mesenchymal stem cells-secreted exosomes (MSCs-Exos) have the potential to cure AD.Aims The first three-arm, drug-interven...

Full description

Bibliographic Details
Main Authors: Ping Li, Chao Gao, Jianping Li, Gang Wang, Xiaoling Gao, Rujing Ren, Ran Tang, Jintao Wang, Xinyi Xie, Shishuang Cui, Jing Chang, Qingxiang Song, Chengxiang Dai, Suke Li, Hongzhuan Chen, Shengdi Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:General Psychiatry
Online Access:https://gpsych.bmj.com/content/36/5/e101143.full

Internet

https://gpsych.bmj.com/content/36/5/e101143.full

Similar Items